Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
Data from the SPARK Study: Mutational Analysis of Patients with Primary Resistance to Ibrutinib in Relapsed/Refractory Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
— January 9, 2015
Read Article
International Research Agenda for Multicentric Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
— January 9, 2015
Read Article
Updates on Treatments for Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
— January 9, 2015
Read Article
Pathology and Diagnosis of Multicentric Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
— January 9, 2015
Read Article
The Clinical Features of Multicentric Castleman's Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
— January 9, 2015
Read Article
Multicentric Castleman’s Disease Overview and Update on Its Pathogenesis
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
— January 9, 2015
Read Article
Enzalutamide Long-Term Safety and Efficacy in Hormone-Naïve Prostate Cancer
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
— September 30, 2014
Read Article
Maximal Androgen Depletion with Abiraterone Acetate Followed by Molecular-Targeted Therapies in Metastatic Prostate Cancer: Finding an Androgen-Signaling Signature to Predict Response
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
— September 30, 2014
Read Article
Chemohormonal Therapy versus Hormonal Therapy Alone in Men with Metastatic Prostate Cancer
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
— September 30, 2014
Read Article
AR-V7 Splice Variant as Prognostic Marker for Resistance to Enzalutamide or Abiraterone in Men with Metastatic Prostate Cancer
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
— September 30, 2014
Read Article
Page 35 of 44
32
33
34
35
36
37
38
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma